Form 8-K - Current report:
SEC Accession No. 0001628280-21-018216
Filing Date
2021-09-08
Accepted
2021-09-08 16:00:55
Documents
61
Period of Report
2021-09-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20210908.htm   iXBRL 8-K 39562
2 EX-99.1 a991ex090821.htm EX-99.1 35175
3 EX-99.2 a992ex090821.htm EX-99.2 42540
7 GRAPHIC a992ex090821001.jpg GRAPHIC 63241
8 GRAPHIC a992ex090821002.jpg GRAPHIC 187410
9 GRAPHIC a992ex090821003.jpg GRAPHIC 100810
10 GRAPHIC a992ex090821004.jpg GRAPHIC 121240
11 GRAPHIC a992ex090821005.jpg GRAPHIC 149793
12 GRAPHIC a992ex090821006.jpg GRAPHIC 60625
13 GRAPHIC a992ex090821007.jpg GRAPHIC 48105
14 GRAPHIC a992ex090821008.jpg GRAPHIC 105598
15 GRAPHIC a992ex090821009.jpg GRAPHIC 70673
16 GRAPHIC a992ex090821010.jpg GRAPHIC 80207
17 GRAPHIC a992ex090821011.jpg GRAPHIC 101684
18 GRAPHIC a992ex090821012.jpg GRAPHIC 99214
19 GRAPHIC a992ex090821013.jpg GRAPHIC 92527
20 GRAPHIC a992ex090821014.jpg GRAPHIC 96842
21 GRAPHIC a992ex090821015.jpg GRAPHIC 97830
22 GRAPHIC a992ex090821016.jpg GRAPHIC 112583
23 GRAPHIC a992ex090821017.jpg GRAPHIC 85068
24 GRAPHIC a992ex090821018.jpg GRAPHIC 80101
25 GRAPHIC a992ex090821019.jpg GRAPHIC 122548
26 GRAPHIC a992ex090821020.jpg GRAPHIC 67638
27 GRAPHIC a992ex090821021.jpg GRAPHIC 97417
28 GRAPHIC a992ex090821022.jpg GRAPHIC 126968
29 GRAPHIC a992ex090821023.jpg GRAPHIC 87981
30 GRAPHIC a992ex090821024.jpg GRAPHIC 109576
31 GRAPHIC a992ex090821025.jpg GRAPHIC 146787
32 GRAPHIC a992ex090821026.jpg GRAPHIC 80433
33 GRAPHIC a992ex090821027.jpg GRAPHIC 118002
34 GRAPHIC a992ex090821028.jpg GRAPHIC 124318
35 GRAPHIC a992ex090821029.jpg GRAPHIC 103259
36 GRAPHIC a992ex090821030.jpg GRAPHIC 165737
37 GRAPHIC a992ex090821031.jpg GRAPHIC 111879
38 GRAPHIC a992ex090821032.jpg GRAPHIC 125358
39 GRAPHIC a992ex090821033.jpg GRAPHIC 116610
40 GRAPHIC a992ex090821034.jpg GRAPHIC 70113
41 GRAPHIC a992ex090821035.jpg GRAPHIC 93813
42 GRAPHIC a992ex090821036.jpg GRAPHIC 135267
43 GRAPHIC a992ex090821037.jpg GRAPHIC 109753
44 GRAPHIC a992ex090821038.jpg GRAPHIC 112020
45 GRAPHIC a992ex090821039.jpg GRAPHIC 44052
46 GRAPHIC a992ex090821040.jpg GRAPHIC 68980
47 GRAPHIC a992ex090821041.jpg GRAPHIC 101509
48 GRAPHIC a992ex090821042.jpg GRAPHIC 81547
49 GRAPHIC a992ex090821043.jpg GRAPHIC 107761
50 GRAPHIC a992ex090821044.jpg GRAPHIC 87880
51 GRAPHIC a992ex090821045.jpg GRAPHIC 98140
52 crdf-20210908_g1.jpg GRAPHIC 176318
53 image_0.jpg GRAPHIC 50931
  Complete submission text file 0001628280-21-018216.txt   7080324

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20210908.xsd EX-101.SCH 1935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20210908_lab.xml EX-101.LAB 23007
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20210908_pre.xml EX-101.PRE 12131
54 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20210908_htm.xml XML 10069
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 211242014
SIC: 2836 Biological Products, (No Diagnostic Substances)